One in ten adults suffer from chronic kidney disease (CKD), a condition characterized by progressive loss of kidney function.

The ACR has released a summary of a new 2024 guideline for the screening, treatment, and management of Lupus Nephritis.

New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of chronic kidney disease.

Taking the drug may also increase the risk of chronic kidney disease by 19%, heart failure by 9% and hypertension by 7%.

Washington: During ACR Convergence 2024, the American College of Rheumatology (ACR) unveiled a summary of the 2024 Guideline ...

A concerning new study has revealed links between regular paracetamol usage and several life-threatening health issues ...

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...

The Global Chronic Kidney Disease Treatment Market was valued at approximately USD 32 billion in 2022 and is projected to grow at a healthy CAGR of more than 4% during the forecast period from 2023 to ...

Paracetamol, a common over-the-counter medication, may increase the risk of gastrointestinal, heart- and kidney-related ...

Introduction Chronic kidney disease (CKD) and end-stage renal disease (ESRD) represent significant public health challenges, ...

New research, led by experts at the University of Nottingham, has found that repeated doses of paracetamol in people aged 65 ...